Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results ; volume:8 ; number:1 ; day:9 ; month:4 ; year:2013 ; pages:1-7 ; date:12.2013
Radiation oncology ; 8, Heft 1 (9.4.2013), 1-7, 12.2013
- Creator
-
Aluwini, Shafak
- Contributor
-
van Rooij, Peter
Hoogeman, Mischa
Kirkels, Wim
Kolkman-Deurloo, Inger-Karine
Bangma, Chris
SpringerLink (Online service)
- DOI
-
10.1186/1748-717X-8-84
- URN
-
urn:nbn:de:1111-201604097857
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aluwini, Shafak
- van Rooij, Peter
- Hoogeman, Mischa
- Kirkels, Wim
- Kolkman-Deurloo, Inger-Karine
- Bangma, Chris
- SpringerLink (Online service)
Other Objects (12)
Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review
Lacosamide as monotherapy in focal seizure: Literature review
Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm
Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol
Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer
Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer
Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review
Lacosamide as monotherapy in focal seizure: Literature review
Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm
Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol
Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer
Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer
Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review
Lacosamide as monotherapy in focal seizure: Literature review
Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm
Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol
Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer
Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer